基本信息
views: 1
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
I am a physician scientist with training in Internal Medicine and Infectious Diseases, and expertise in the development of biologics, vaccines, and small molecules. I have published approximately 170 manuscripts, review articles, and book chapters, mainly in the areas of anti-infective drug development, biomarkers, and immunotherapy. My publication indices are summarized here at Google Scholar.
My career shifted from academia to industry in 2004, when I led a successful bid by PPD, a contract research organization, to win what at the time was the largest contract in the history of the US NIAID, managing the international trials of its Division of AIDS. I came to Pfizer in 2008 as the Therapeutic Area Clinical Lead for Infectious Diseases, where my responsibilities included clinical development of a wide range of antibacterials, antivirals, antifungals, sepsis therapies, and therapeutic antibodies. I provided oversight of trial designs, development plans, and regulatory strategies. I also served as clinical lead for the development of sutezolid, an oxazolidinone antimicrobial for the treatment of tuberculosis. Pfizer completed the first study of sutezolid in TB patients.
In 2014 I joined the Aurum Institute as Chief Science Officer, where I am responsible for developing Aurum's program of biomedical research on TB and HIV. Our current projects include studies of host-directed TB therapy funded by the Gates foundation, the German Ministry of Education and Research (BMBF), US NIH, the European Commission (Horizon 2020), and EDCTP. We also are studying individuals who have been heavily exposed to active TB cases but who have remained tuberculin skin test (TST) and IFNg (QFT) negative (funded by the Gates foundation and NIH). I also serve as a member of the editorial board of the Journal of Infectious Diseases and am a member of the external scientific advisory board of the German Center for Infection Research (DZIF).
Research Interests
Papers共 248 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Rebecca N. Jerome, Laura A. Zahn, Jessica J. Abner,Meghan M. Joly,Jana K. Shirey-Rice,Robert S. Wallis,Gordon R. Bernard,Jill M. Pulley
TRANSLATIONAL GASTROENTEROLOGY AND HEPATOLOGY (2024)
Elsevier eBookspp.52-71, (2024)
Cited0Views0Bibtex
0
0
Rebecca N Jerome, Laura A Zahn, Jessica J Abner,Meghan M Joly,Jana K Shirey-Rice,Robert S Wallis,Gordon R Bernard,Jill M Pulley
Translational gastroenterology and hepatology (2024): 2-2
Pholo Maenetje,Yeonsoo Baik,Diana B Schramm, Mboyo Di-Tamba Willy Vangu,Robert S Wallis,Mandla Mlotshwa,Caroline T Tiemessen, Yun Li,Hardy Kornfeld,Gavin Churchyard,Sara C Auld,Gregory P Bisson
The Journal of infectious diseasesno. 3 (2024): 824-832
A. Rachow,O. Ivanova, A. Bakuli,C. Khosa, P. Nhassengo,O. Owolabi,S. Jayasooriya,N. E. Ntinginya,I. Sabi, M. Rassool, J. Bennet, S. Niemann,
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Diseaseno. 11 (2023): 850-+
Cited0Views0Bibtex
0
0
BMC pulmonary medicineno. 1 (2023): 53-53
The American journal of tropical medicine and hygieneno. 1 (2022): 235-236
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn